Factors associated with sustained virological response in 24‐week telaprevir‐based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype
暂无分享,去创建一个
T. Ide | M. Sata | A. Tsubota | H. Toyoda | C. Sakamoto | T. Kumada | Y. Aizawa | K. Takaguchi | N. Shimada | M. Atsukawa | Keizo Kato | H. Abe | T. Asano | Y. Chuganji